|
|
 |
Registry of Lobbyists - Mark Oakley
To find further information on a company or organization check the Registry of Joint Stock Companies
|
|
| Registration Number | Status | | | 2527 | Inactive | | | Initial registration date | Last date of any changes | | 22-June-2022 | 22-June-2022 |
|
Lobbyist's Last Name
Oakley |
Lobbyist's First Name
Mark |
Middle Initial
|
|
Business Address of Lobbyist
385 Bouchard Blvd |
City
Dorval |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9S 1A9 |
Telephone
902 890-4934 |
Fax
|
| |
Business or Firm Name for Lobbyist (if applicable)
Novartis Pharmaceuticals Canada Inc. |
Registry of Joint Stock Companies Number
3052798 |
Business Address of Lobbyist's Business or Firm
385 Bouchard Blvd |
City
Dorval |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9S 1A9 |
Telephone
514 631-6775 |
Fax
|
|
|
No other beneficiaries of lobbying activities
|
|
|
|
Description of Employer's Business:
As a pharmaceutical manufacturer, our mission is to use science-based innovation to develop breakthrough treatments and find innovative ways to deliver them to as many patients as possible - as quickly as possible. |
| |
|
|
|
| Description |
|
| Novartis is interested in policies, laws and regulations related to the access to medicines and their value within the broader context of the health care system and innovation policies. More precisely, Novartis will engage in lobbying activities regarding the introduction and access of innovative therapies by the Nova Scotia Drug Program as well as medicines dispensed in Hospitals of the province. I will work with health care decision makers regarding health policy, outcomes, and access to new medications. |
View
|
|
|
|
|
|
No funding from any government or agency
|
|
No private funding related to lobbying activities
|
|
|
|
|
